Announcements Trials
Browse Landscape

Status

Unknown 1Terminated 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 10Breast Diseases 2Sexuality 1Polycystic Ovary Syndrome 1Neoplasms, Hormone-Dependent 1Luminal B/HER2-negative Breast Cancer 1Infertility 1Hormone-receptor-positive Breast Cancer 1Hormone Receptor Positive Advanced Breast Cancer 1Bulbo-Spinal Atrophy, X-Linked 1Advanced Breast Cancer 1

Interventions

Fulvestrant 5Letrozole 4Capecitabine 3pyrotinib 2Paclitaxel 2Goserelin 2Anastrozole 2palbociclib 1olaparib 1neratinib 1liposomal doxorubicin 1exemestane 1entinostat 1ceralasertib 1capivasertib 1Vinorelbine 1Trastuzumab 1Standard of Care 1N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1Injections 1In Situ Hybridization, Fluorescence 1Immunotherapy, Adoptive 1Gonadotropin-Releasing Hormone 1FCN-437c 1Docetaxel 1Decitabine 1Cyclophosphamide 1Combined Modality Therapy 1Cisplatin 1CYH33 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Advanced Breast Cancer × Aromatase Inhibitors × Clear all
NCT01311037 2011-12-13

The Combination of GnRh Analogue and Aromatase Inhibitor in Receptor Positive Premenopausal Women With Advanced Breast Cancer

King Faisal Specialist Hospital & Research Center

Unknown
2 enrolled
Breast

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡